In this final analysis , 129 patients ( 437 % , 95 % CI 381-494 ) in the carboplatin group achieved a pathological complete response , compared with 108 patients ( 369 % , 313-424 ) without carboplatin ( odds ratio 133 , 95 % CI 096-185 ; p = 0107 ) .